Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • The Clinical Frailty Scale is...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Export Ready — 
The Clinical Frailty Scale is superior to the Karnofsky Performance Status as predictor of overall survival in patients with surgical treatment of brain metastases

The Clinical Frailty Scale is superior to the Karnofsky Performance Status as predictor of overall survival in patients with surgical treatment of brain metastases

Bibliographic Details
Main Authors: N. Pichler, A. Krigers, J. Kerschbaumer, M. Demetz, J. Klingenschmid, C. Thomé, C.F. Freyschlag
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Brain and Spine
Online Access:http://www.sciencedirect.com/science/article/pii/S277252942200652X
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S277252942200652X

Similar Items

  • Clinical Frailty Scale and Karnofsky Performance Status are Superior to Temporal Muscle Thickness in Survival Prediction in Brain Metastasis Patients
    by: Aleksandrs Krigers, et al.
    Published: (2023-01-01)
  • An assessment of predictive factors for overall survival in glioblastoma – MGMT methylation is solely important for younger patients
    by: T. Cosar, et al.
    Published: (2022-01-01)
  • Correlation of Clinical Frailty Scale with IDH mutation and MGMT methylation in high-grade glioma
    by: J. Klingenschmid, et al.
    Published: (2021-01-01)
  • Impact of GAP-43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas
    by: A. Krigers, et al.
    Published: (2022-01-01)
  • Now you see me - the use of sodium fluoresceine for resection of brain metastases
    by: J. Kerschbaumer, et al.
    Published: (2022-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs